Downstream Processing

Industry must ensure tech not used to make bioweapons says UN

EDITOR'S BLOG

BioPharma Tech Firms Can Help Prevent Bioweapon Production, Says UN

By Gareth Macdonald

Making germ warfare weapons is banned under the Biological Weapons Convention (BWC) and there is no evidence signatories or even countries led by any of the World’s crackpot dictators/freedom fighters* are producing them.

More Manufacturing Issues Lead to Alexion Recall

More Manufacturing Issues Lead to Alexion Recall

By Dan Stanton

Alexion Pharma International has recalled a single lot of its monoclonal antibody (MAb) orphan drug Soliris due to the presence of visible particles in a limited number of vials.

Biopharma Companies Look to New Chromatography Columns

Biopharma Companies Look to New Chromatography Columns

By Zachary Brennan

Biopharma firms, particularly those producing insulin and five of its analogues, have another option in the market of sub-2 micron solid-core chromatography columns with a recent offering from Waters.

Catalent to replace steel bioreactors with single use

Catalent plans single use overhaul of bioreactors

By Natalie Morrison

Catalent has replaced all stainless steel bioreactors at its biologics facility in Middleton, Wisconsin with single-use techs citing cost and flexibility advantages.

West shifts focus to proprietary products

West shifts focus to proprietary products

By Natalie Morrison

West Pharmaceutical is changing its gauge from contract manufacturing to proprietary products: it’s particular focus, delivery systems.

Follow us

Webinars